Carregant...

Infiltrative lung diseases: Complications of novel antineoplastic agents in patients with hematological malignancies

Infiltrative lung disease is a well-known complication of antineoplastic agents in patients with hematological malignancies. Novel agents are constantly being added to available treatments. The present review discusses different pulmonary syndromes, pathogenesis and management of these novel agents.

Guardat en:
Dades bibliogràfiques
Autors principals: Vahid, Bobbak, Marik, Paul E
Format: Artigo
Idioma:Inglês
Publicat: Pulsus Group Inc 2008
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2677954/
https://ncbi.nlm.nih.gov/pubmed/18551203
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!